B

Blue Jet Healthcare Ltd
NSE:BLUEJET

Watchlist Manager
Blue Jet Healthcare Ltd
NSE:BLUEJET
Watchlist
Price: 418.2 INR 0.49% Market Closed
Market Cap: ₹72.5B

Operating Margin

35.5%
Current
Improving
by 2.8%
vs 3-y average of 32.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
35.5%
=
Operating Income
₹4.2B
/
Revenue
₹11.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
35.5%
=
Operating Income
₹4.2B
/
Revenue
₹11.8B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Blue Jet Healthcare Ltd
NSE:BLUEJET
73B INR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
975.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
549.3B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
388.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...

Market Distribution

Higher than 91% of companies in India
Percentile
91st
Based on 5 437 companies
91st percentile
35.5%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Blue Jet Healthcare Ltd
Glance View

Market Cap
72.5B INR
Industry
N/A

Blue Jet Healthcare Ltd is a IN-based company operating in industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-11-01. Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.

BLUEJET Intrinsic Value
435.58 INR
Undervaluation 4%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
35.5%
=
Operating Income
₹4.2B
/
Revenue
₹11.8B
What is Blue Jet Healthcare Ltd's current Operating Margin?

The current Operating Margin for Blue Jet Healthcare Ltd is 35.5%, which is above its 3-year median of 32.7%.

How has Operating Margin changed over time?

Over the last 1 years, Blue Jet Healthcare Ltd’s Operating Margin has increased from 26.2% to 35.5%. During this period, it reached a low of 26.2% on Aug 30, 2024 and a high of 35.6% on Jun 30, 2025.

Back to Top